Testing effectiveness (Phase 2)Study completedNCT00987922What this trial is testingMild Hypothermia in Acute Ischemic StrokeWho this might be right forBrain Ischemia University of Helsinki 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT06093841What this trial is testingRelmacabtagene Autoleucel As Second-Line Therapy in Adult Patients with Aggressive B-cell NHLWho this might be right forLymphoma, Large B-Cell, DiffuseFollicular Lymphoma Grade 3BHigh-grade B-cell Lymphoma+1 more Shanghai Ming Ju Biotechnology Co., Ltd. 46
Early research (Phase 1)Study completedNCT02996773What this trial is testingHaploidentical BMT With Post-Transplant Cyclophosphamide and BendamustineWho this might be right forAcute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaMyelodysplastic Syndromes+10 more University of Arizona 50
Early research (Phase 1)Study completedNCT00003294What this trial is testingChemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic CancerWho this might be right forLeukemiaLymphomaUnspecified Adult Solid Tumor, Protocol Specific Roswell Park Cancer Institute 24
Testing effectiveness (Phase 2)Study completedNCT00006251What this trial is testingFludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic CancerWho this might be right forAcute Undifferentiated LeukemiaAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+61 more Fred Hutchinson Cancer Center 21
Large-scale testing (Phase 3)Study completedNCT00004031What this trial is testingSWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma SWOG Cancer Research Network 397
Early research (Phase 1)WithdrawnNCT02657447What this trial is testingDosimetry Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-02)Who this might be right forNon-Hodgkin Lymphoma Nordic Nanovector
Early research (Phase 1)Ended earlyNCT03320642What this trial is testingGRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host DiseaseWho this might be right forHematologic Malignancies Incyte Corporation 84
Large-scale testing (Phase 3)Looking for participantsNCT06724237What this trial is testingTesting Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial ChemotherapyWho this might be right forAnaplastic Large Cell Lymphoma, ALK-NegativeFollicular Helper T-Cell LymphomaFollicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type+1 more Eastern Cooperative Oncology Group
Early research (Phase 1)Study completedNCT00058227What this trial is testingAlvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell LymphomaWho this might be right forB-cell Chronic Lymphocytic LeukemiaContiguous Stage II Grade 1 Follicular LymphomaContiguous Stage II Grade 2 Follicular Lymphoma+40 more National Cancer Institute (NCI) 37
Not applicableUnknownNCT01231269What this trial is testingWhole-body Diffusion-weighted Magnetic Resonance Imaging for Staging and Treatment Prediction of LymphomaWho this might be right forLymphomaHodgkin LymphomaNon-Hodgkin Lymphoma (Follicular, Diffuse B-cel Lymphoma, PTLD and Mantle Cel Lymphoma) Universitaire Ziekenhuizen KU Leuven 100
Testing effectiveness (Phase 2)Study completedNCT00634179What this trial is testingA Phase I/II Trial of VR-CHOP in Lymphoma PatientsWho this might be right forLymphoma, B-CellFollicular Lymphoma Emory University 37
Not applicableUnknownNCT02667366What this trial is testingEffectiveness and Cost-effectiveness of Telephone-delivered Psychotherapy for Depression in Primary CareWho this might be right forDepression University of Zurich 56
Post-approval studies (Phase 4)Study completedNCT02519595What this trial is testingOptimal Dosing of Ketamine for Procedural Sedation and Analgesia in ChildrenWho this might be right forModerate, Deep Sedation Children's Hospital of Michigan 182
Early research (Phase 1)Looking for participantsNCT07546760What this trial is testingA Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234Who this might be right forHepatic Impairment AstraZeneca 28
Not applicableStudy completedNCT04859920What this trial is testingLiving Conditions of Patients With Diffuse Large B-Cell Lymphoma or Follicular Lymphoma in the Côte d'Or RegionWho this might be right forDiffuse Large Cell Diffuse LymphomaFollicular Lymphoma Centre Hospitalier Universitaire Dijon 157
Early research (Phase 1)Study completedNCT00003166What this trial is testingBryostatin and Vincristine in B-Cell MalignanciesWho this might be right forRecurrent Adult Burkitt LymphomaRecurrent Adult Diffuse Large Cell LymphomaRecurrent Adult Diffuse Mixed Cell Lymphoma+7 more National Cancer Institute (NCI) 18
Large-scale testing (Phase 3)Study completedNCT03993288What this trial is testingStudy to Test the Hypothesis of Non-inferior Efficacy and Safety of Ferrum Lek® (Iron (III) Hydroxide Polymaltosate), 100 mg Chewable Tablets (Lek d.d., Slovenia), as Compared With MALTOFER® (Vifor S.A., Switzerland), in Subjects With Mild and Moderate Iron Deficiency Anemia.Who this might be right forMild and Moderate Iron-deficiency Anaemia Sandoz 267
Early research (Phase 1)WithdrawnNCT02743546What this trial is testingStudy of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Duvortuxizumab (JNJ-64052781) Plus Ibrutinib in LymphomaWho this might be right forLeukemia, Lymphocytic, Chronic, B-CellLymphoma, Large B-Cell, DiffuseLymphoma, Follicular+1 more Janssen Research & Development, LLC
Large-scale testing (Phase 3)Study completedNCT01987505What this trial is testingMabRella Study: A Study to Evaluate the Safety of Switching From Intravenous to Subcutaneous Administration of Rituximab During First-Line Treatment for LymphomaWho this might be right forLymphoma, Non Hodgkin Hoffmann-La Roche 140